ARANSCIA
LIVE

Serial Number

97537158

Owner

AccessDx Laboratory, LLC

Attorney

Donna A. Tobin

First Use Date

Dec 21, 2022

Filing Date

Aug 5, 2022

Add to watchlist:

No watchlists yet
View on USPTO

ARANSCIA Trademark

Serial Number: 97537158 • Registration: 7779109

ARANSCIA is a trademark filed by AccessDx Laboratory, LLC on August 5, 2022. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

AccessDx Laboratory, LLC (4 trademarks)

Suite #400
Houston, TX 77025

Entity Type: 16

Trademark Details

Filing Date

August 5, 2022

Registration Date

April 29, 2025

First Use Anywhere

December 21, 2022

First Use in Commerce

January 5, 2023

Published for Opposition

May 21, 2024

Goods & Services

Medical services, namely, providing medical information in the field of genomics, medical diagnostic testing, clinical testing, precision medicine, and medical consultation services in the nature of presenting clinical risk insights and recommendations of customized therapies based on diagnostic testing, clinical decision support, clinical outcomes, and population health management; the aforementioned being provided via clinical software and none being for conducting clinical trial for others, clinical and medical research, providing scientific research in the field of clinical trials, conducting pharmaceutical clinical trials for others, research on the subject of pharmaceuticals, consultancy in relation to scientific research, scientific consultancy services, consulting services in the fields of biotechnology pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics, pharmaceutical research and development, research and development of pharmaceuticals

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 29, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 29, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 9, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 9, 2025 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 21, 2025 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Mar 21, 2025 SUPC
SOU EXTENSION 1 GRANTED
Mar 21, 2025 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 21, 2025 AITU
USE AMENDMENT FILED
Jan 16, 2025 IUAF
SOU EXTENSION 1 FILED
Jan 16, 2025 EXT1
TEAS STATEMENT OF USE RECEIVED
Jan 16, 2025 EISU
SOU TEAS EXTENSION RECEIVED
Jan 16, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 16, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 21, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 21, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 1, 2024 NONP
EXPARTE APPEAL TERMINATED
Apr 12, 2024 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 12, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 11, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 11, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 11, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 11, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 8, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 8, 2024 CRFA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 30, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 30, 2024 CRFA
ASSIGNED TO LIE
Jan 30, 2024 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 8, 2023 ERFR
EX PARTE APPEAL-INSTITUTED
Sep 8, 2023 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Sep 8, 2023 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Sep 8, 2023 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 8, 2023 GNFN
FINAL REFUSAL E-MAILED
Jun 8, 2023 GNFR
FINAL REFUSAL WRITTEN
Jun 8, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 20, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 19, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 19, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 19, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 19, 2022 GNRT
NON-FINAL ACTION WRITTEN
Oct 19, 2022 CNRT
ASSIGNED TO EXAMINER
Oct 19, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 27, 2022 NWOS
NEW APPLICATION ENTERED
Aug 9, 2022 NWAP